Current research at Weill Cornell and the New York Genome Center
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
When should we start treatment for relapsed multiple myeloma patients?
Challenges associated with long-term therapies in CLL